Natdac Medicines (Daclatasvir) is a drug for the treatment of hepatitis C (HCV). it is approved for Hepatitis C genotype 3 infections. Daclatasvir inhibits the HCV nonstructural protein NS5A. Recent research suggests that it targets two steps of the viral replication process, enabling rapid decline of HCV RNA. Daclatasvir has been tested in combination regimens with pegylated interferonand ribavirin, as well as with other direct-acting antiviral agents including asunaprevir and sofosbuvir.
- Minimum Order Quantity: 3 un